Market overview
The global polymerase chain reaction market is worth USD 11.6 bn in 2026 and is forecast to reach USD 21.7 bn by 2036, growing at a 6.5% CAGR. United States is the largest country market and Reagents and consumables is the largest by product segment.
| Scope | Polymerase chain reaction instruments, reagents, consumables and software for amplifying DNA and RNA in clinical diagnostics, research, pharma and forensic laboratories. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 11.0 bn |
| Value 2026 | USD 11.6 bn |
| Value 2036 | USD 21.7 bn |
| CAGR 2026-2036 | 6.5% |
| Volume 2026 | 1,871 million tests |
| Volume 2036 | 3,180 million tests |
| Average price 2026 | USD 6.17 per test |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Polymerase Chain Reaction market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 11.6 bn |
| 2027 | USD 12.3 bn |
| 2028 | USD 13.1 bn |
| 2029 | USD 14.0 bn |
| 2030 | USD 14.9 bn |
| 2031 | USD 15.8 bn |
| 2032 | USD 16.9 bn |
| 2033 | USD 17.9 bn |
| 2034 | USD 19.1 bn |
| 2035 | USD 20.4 bn |
| 2036 | USD 21.7 bn |
Polymerase Chain Reaction market segmentation
By product
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Reagents and consumables | 62.0% | 61.5% | USD 7.2 bn | 6.4% |
| Instruments | 28.0% | 26.5% | USD 3.2 bn | 5.9% |
| Software and services | 10.0% | 12.0% | USD 1.2 bn | 8.4% |
By technology
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Real-time PCR | 52.0% | 48.7% | USD 6.0 bn | 5.8% |
| Conventional PCR | 20.0% | 14.7% | USD 2.3 bn | 3.3% |
| Digital PCR | 14.0% | 20.8% | USD 1.6 bn | 10.8% |
| Multiplex and specialty | 14.0% | 15.8% | USD 1.6 bn | 7.8% |
By end use
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Clinical diagnostics | 48.0% | 48.4% | USD 5.5 bn | 6.6% |
| Academic and research | 26.0% | 23.9% | USD 3.0 bn | 5.6% |
| Pharma and biotech | 16.0% | 18.6% | USD 1.8 bn | 8.1% |
| Forensic and other | 10.0% | 9.2% | USD 1.2 bn | 5.6% |
By application
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Infectious disease | 34.0% | 28.0% | USD 3.9 bn | 4.5% |
| Oncology | 22.0% | 26.0% | USD 2.5 bn | 8.3% |
| Genetic testing | 14.0% | 16.0% | USD 1.6 bn | 7.9% |
| Research and gene expression | 20.0% | 20.0% | USD 2.3 bn | 6.5% |
| Food and environmental | 10.0% | 10.0% | USD 1.2 bn | 6.5% |
By sample throughput
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Low under 96 well | 30.0% | 26.0% | USD 3.5 bn | 5.0% |
| Mid range | 38.0% | 38.0% | USD 4.4 bn | 6.5% |
| High throughput automated | 32.0% | 36.0% | USD 3.7 bn | 7.8% |
Top 25 countries for polymerase chain reaction by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 82.0% of 2026 revenue and the 25 countries below together hold 94.6%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 3.9 bn | 34.0% | USD 7.0 bn | 5.9% |
| 2 | China | USD 1.6 bn | 14.0% | USD 3.6 bn | 8.4% |
| 3 | Germany | USD 808 mn | 7.0% | USD 1.4 bn | 5.4% |
| 4 | Japan | USD 578 mn | 5.0% | USD 932 mn | 4.9% |
| 5 | United Kingdom | USD 578 mn | 5.0% | USD 1.0 bn | 5.8% |
| 6 | France | USD 462 mn | 4.0% | USD 781 mn | 5.4% |
| 7 | India | USD 462 mn | 4.0% | USD 1.2 bn | 9.9% |
| 8 | Italy | USD 346 mn | 3.0% | USD 585 mn | 5.4% |
| 9 | South Korea | USD 346 mn | 3.0% | USD 672 mn | 6.8% |
| 10 | Canada | USD 346 mn | 3.0% | USD 607 mn | 5.8% |
| 11 | Spain | USD 323 mn | 2.8% | USD 557 mn | 5.6% |
| 12 | Netherlands | USD 193 mn | 1.7% | USD 332 mn | 5.6% |
| 13 | Switzerland | USD 142 mn | 1.2% | USD 245 mn | 5.6% |
| 14 | Australia | USD 114 mn | 1.0% | USD 197 mn | 5.6% |
| 15 | Brazil | USD 97 mn | 0.8% | USD 236 mn | 9.3% |
| 16 | Russia | USD 84 mn | 0.7% | USD 145 mn | 5.6% |
| 17 | Taiwan | USD 75 mn | 0.7% | USD 130 mn | 5.7% |
| 18 | Belgium | USD 68 mn | 0.6% | USD 117 mn | 5.6% |
| 19 | Sweden | USD 62 mn | 0.5% | USD 108 mn | 5.7% |
| 20 | Singapore | USD 58 mn | 0.5% | USD 141 mn | 9.3% |
| 21 | Mexico | USD 53 mn | 0.5% | USD 132 mn | 9.6% |
| 22 | Turkey | USD 50 mn | 0.4% | USD 124 mn | 9.5% |
| 23 | Thailand | USD 47 mn | 0.4% | USD 115 mn | 9.3% |
| 24 | Saudi Arabia | USD 45 mn | 0.4% | USD 111 mn | 9.4% |
| 25 | Poland | USD 43 mn | 0.4% | USD 104 mn | 9.3% |
| Rest of world | USD 624 mn | 5.4% | USD 1.1 bn | 6.1% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Thermo Fisher Scientific
- Roche
- Bio-Rad Laboratories
- QIAGEN
- Danaher
- Abbott
Group 2: Regional and specialist players
- Agilent Technologies
- Takara Bio
- Hologic
- bioMerieux
- Cepheid
- Revvity
- Seegene
- Eppendorf
- DiaSorin
Group 3: Emerging and niche players
- Sansure Biotech
- Analytik Jena
- Daan Gene
- Bioer Technology
- Bioneer
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the polymerase chain reaction market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 6.5% is calculated from the resulting values.
The market is divided by product, by technology, by end use, by application, by sample throughput. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the polymerase chain reaction market?
The global polymerase chain reaction market is estimated at USD 11.0 bn in 2025 and USD 11.6 bn in 2026.
How fast will the polymerase chain reaction market grow?
It is forecast to reach USD 21.7 bn by 2036, a compound annual growth rate of 6.5% from 2026, an increase of USD 10.1 bn.
Which country is the largest market for polymerase chain reaction?
United States is the largest market by revenue at USD 3.9 bn in 2026, 34.0% of the global total. The three largest countries together hold 55.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 9.9% a year from 2026 to 2036.
Which polymerase chain reaction segment is largest?
In the by product split, Reagents and consumables is the largest segment with 62.0% of 2026 revenue.
Who are the leading polymerase chain reaction companies?
Global leaders include Thermo Fisher Scientific, Roche, Bio-Rad Laboratories, QIAGEN.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Sterilization EquipmentUSD 11.7 bn · 6.0% CAGR
- Gene TherapyUSD 11.3 bn · 22.0% CAGR
- RadiopharmaceuticalsUSD 12.1 bn · 12.5% CAGR
- Oligonucleotide TherapeuticsUSD 12.2 bn · 16.0% CAGR
- ChromatographyUSD 12.6 bn · 6.0% CAGR
- Implantable Drug DeliveryUSD 12.9 bn · 7.8% CAGR
- Filtration MembraneUSD 10.3 bn · 8.5% CAGR
- FermentationUSD 10.3 bn · 8.5% CAGR
← Point-of-Care Respiratory Diagnostic Panels Precision Medicine →